SE8400283L - Sett att framstella virusstammar som stimulerer en verdorganisms naturliga forsvarsmekanism utan att samtidigt verka antigent - Google Patents
Sett att framstella virusstammar som stimulerer en verdorganisms naturliga forsvarsmekanism utan att samtidigt verka antigentInfo
- Publication number
- SE8400283L SE8400283L SE8400283A SE8400283A SE8400283L SE 8400283 L SE8400283 L SE 8400283L SE 8400283 A SE8400283 A SE 8400283A SE 8400283 A SE8400283 A SE 8400283A SE 8400283 L SE8400283 L SE 8400283L
- Authority
- SE
- Sweden
- Prior art keywords
- virus
- attenuated
- stimulate
- cattle
- dec
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16732—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16761—Methods of inactivation or attenuation
- C12N2710/16764—Methods of inactivation or attenuation by serial passage
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Claims (1)
1. Patentkrav Satt att framstalla ett interferoninducerande medel, k a n - netecknat av att man oasserar en virusstam med i och fIr sip kanda metoder pit vavnadskultur av djurceller vid 36 - - °C sit lange, tills less att enligt vanliga testforfaranden, &Acorn t. ex. serumneutralisationstestet, dubbeldiffusionsmetoden teller immunelektrofores ingen antikroppsbildning not utgangsviruset kan pAvisas och man erhaller en virusospecifik interferoninducering, pAvisad teed en venlig testmetod, sAsom t.ex. Plague-reduktionsmetoden, reduktion av virus-hanagglutinintitern eller den kvantitativa hamadsorptionsmetoden och OverfOr den sit passerade virusstammen pit i och fOr sig kant satt till en bruksfardig form.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2161344A DE2161344C3 (de) | 1971-12-10 | 1971-12-10 | Herstellung von Virusstämmen, welche die natürlichen Abwehrmechanismen eines Wirtsorganismus stimulieren, ohne dabei gleichzeitig antigen zu wirken und Arzneimittel zur Prophylaxe und Behandlung von viralen und bakteriellen Infektionen des Menschen und der Tiere, einen solchen Virusstamm enthaltend |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE8400283D0 SE8400283D0 (sv) | 1984-01-20 |
| SE8400283L true SE8400283L (sv) | 1984-01-20 |
Family
ID=5827622
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8400283A SE8400283L (sv) | 1971-12-10 | 1984-01-20 | Sett att framstella virusstammar som stimulerer en verdorganisms naturliga forsvarsmekanism utan att samtidigt verka antigent |
Country Status (21)
| Country | Link |
|---|---|
| JP (2) | JPS6011013B2 (sv) |
| AR (1) | AR204075A1 (sv) |
| AT (1) | AT326817B (sv) |
| AU (1) | AU473209B2 (sv) |
| BE (1) | BE792484A (sv) |
| BG (1) | BG21417A3 (sv) |
| CA (1) | CA988848A (sv) |
| CH (1) | CH577558A5 (sv) |
| CS (1) | CS189587B2 (sv) |
| DD (1) | DD108115A5 (sv) |
| DE (1) | DE2161344C3 (sv) |
| DK (1) | DK143201C (sv) |
| ES (1) | ES409464A1 (sv) |
| FR (1) | FR2162637B1 (sv) |
| GB (1) | GB1356076A (sv) |
| HU (1) | HU167086B (sv) |
| IE (1) | IE36995B1 (sv) |
| NL (1) | NL178014C (sv) |
| PH (1) | PH12597A (sv) |
| SE (1) | SE8400283L (sv) |
| ZA (1) | ZA728709B (sv) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0063657A1 (en) * | 1981-04-29 | 1982-11-03 | Merck & Co. Inc. | Topical application of interferon inducers |
-
0
- BE BE792484D patent/BE792484A/xx not_active IP Right Cessation
-
1971
- 1971-12-10 DE DE2161344A patent/DE2161344C3/de not_active Expired
-
1972
- 1972-01-01 AR AR245553A patent/AR204075A1/es active
- 1972-12-01 PH PH14135A patent/PH12597A/en unknown
- 1972-12-05 JP JP47121265A patent/JPS6011013B2/ja not_active Expired
- 1972-12-05 JP JP47121264A patent/JPS5924137B2/ja not_active Expired
- 1972-12-06 BG BG22052A patent/BG21417A3/xx unknown
- 1972-12-07 NL NLAANVRAGE7216628,A patent/NL178014C/xx not_active IP Right Cessation
- 1972-12-07 AT AT1041972A patent/AT326817B/de not_active IP Right Cessation
- 1972-12-07 CS CS728391A patent/CS189587B2/cs unknown
- 1972-12-08 FR FR7243868A patent/FR2162637B1/fr not_active Expired
- 1972-12-08 DK DK615472A patent/DK143201C/da not_active IP Right Cessation
- 1972-12-08 GB GB5672372A patent/GB1356076A/en not_active Expired
- 1972-12-08 DD DD167455A patent/DD108115A5/xx unknown
- 1972-12-08 ZA ZA728709A patent/ZA728709B/xx unknown
- 1972-12-08 CA CA158,535A patent/CA988848A/en not_active Expired
- 1972-12-08 HU HUBA2833A patent/HU167086B/hu unknown
- 1972-12-08 CH CH1791372A patent/CH577558A5/xx not_active IP Right Cessation
- 1972-12-08 IE IE1716/72A patent/IE36995B1/xx unknown
- 1972-12-09 ES ES409464A patent/ES409464A1/es not_active Expired
- 1972-12-11 AU AU49920/72A patent/AU473209B2/en not_active Expired
-
1984
- 1984-01-20 SE SE8400283A patent/SE8400283L/sv not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ATA1041972A (de) | 1975-03-15 |
| DE2161344B2 (de) | 1980-05-08 |
| DE2161344C3 (de) | 1986-10-02 |
| CS189587B2 (en) | 1979-04-30 |
| JPS6011013B2 (ja) | 1985-03-22 |
| AT326817B (de) | 1975-12-29 |
| NL178014B (nl) | 1985-08-01 |
| SE8400283D0 (sv) | 1984-01-20 |
| AR204075A1 (es) | 1975-11-20 |
| BG21417A3 (sv) | 1976-05-20 |
| NL7216628A (sv) | 1973-06-13 |
| GB1356076A (en) | 1974-06-12 |
| ZA728709B (en) | 1973-08-29 |
| HU167086B (sv) | 1975-08-28 |
| SU439956A3 (ru) | 1974-08-15 |
| JPS5924137B2 (ja) | 1984-06-07 |
| FR2162637B1 (sv) | 1976-07-02 |
| DK143201C (da) | 1981-12-14 |
| JPS4862912A (sv) | 1973-09-01 |
| DK143201B (da) | 1981-07-20 |
| FR2162637A1 (sv) | 1973-07-20 |
| AU4992072A (en) | 1974-06-13 |
| DE2161344A1 (de) | 1973-06-20 |
| IE36995L (en) | 1973-06-10 |
| AU473209B2 (en) | 1976-06-17 |
| IE36995B1 (en) | 1977-04-13 |
| PH12597A (en) | 1979-06-27 |
| CA988848A (en) | 1976-05-11 |
| JPS4862919A (sv) | 1973-09-01 |
| BE792484A (fr) | 1973-06-08 |
| ES409464A1 (es) | 1976-03-16 |
| NL178014C (nl) | 1986-01-02 |
| DD108115A5 (sv) | 1974-09-05 |
| CH577558A5 (sv) | 1976-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hirai et al. | The immunodepressive effect of infectious bursal disease virus in chickens | |
| Burnet et al. | The receptor-destroying enzyme of V. cholerae. | |
| Yap et al. | Cytotoxic T cells specific for influenza virus-infected target cells. | |
| Wheelock | Virus replication and high-titered interferon production in human leukocyte cultures inoculated with Newcastle disease virus | |
| Coleman et al. | The HONG KONG/68 influenza A2 variant | |
| Vilček et al. | Differential effects of actinomycin D and puromycin on the release of interferon induced by double stranded RNA | |
| Levy-Koenig et al. | Immunology of Interferons: II. Heterospecific Activities of Human Interferons and Their Neutralization by Antibody | |
| Sumbria et al. | Factors affecting the tissue damaging consequences of viral infections | |
| Kim et al. | Abortive infection of human diploid cells by murine cytomegalovirus | |
| Jensen et al. | Studies of inhibitory effect of ammonium ions in several virus-tissue culture systems | |
| SE8400283L (sv) | Sett att framstella virusstammar som stimulerer en verdorganisms naturliga forsvarsmekanism utan att samtidigt verka antigent | |
| Menegus et al. | Increased efficiency of group B coxsackievirus isolation from clinical specimens by use of BGM cells | |
| Rabinowitz et al. | The formation of variants with a reversion of properties of transformed cells: IV. Loss of detectable polyoma transplantation antigen | |
| Melnick et al. | Immunogenic Potency of MgCl2—Stabilized Oral Poliovaccine | |
| DALOD et al. | Delayed virus-specific CD8+ cytotoxic T lymphocyte activity in an HIV-infected individual with high CD4+ cell counts: correlations with various parameters of disease progression | |
| Lavrov et al. | Combined inhibition of influenza virus reproduction in cell culture using interferon and amantadine | |
| Cairns | The growth of influenza viruses and Newcastle disease virus in mouse brain | |
| Connelly et al. | Virologic studies on acute respiratory disease in young adults. II. Characteristics and serologic studies of three new rhinoviruses | |
| GB1461188A (en) | Live influenza virus vaccines and preparation thereof | |
| Schleicher et al. | Antiviral activity in tissue culture systems of bis-benzimidazoles, potent inhibitors of rhinoviruses | |
| Eaton et al. | Further observations on the effect of 2, 4-dinitrophenol on the growth of influenza virus | |
| Bradburne | An investigation of the replication of coronaviruses in suspension cultures of L132 cells | |
| Degre et al. | Production of an interferon-like agent following inoculation with bacterial vaccine | |
| IL28696A (en) | Attenuated live rubella virus vaccine and method of production | |
| CN110075117A (zh) | 肝素钠作为抑制草鱼呼肠孤病毒感染药物的用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAV | Patent application has lapsed |
Ref document number: 8400283-1 Format of ref document f/p: F |